650 5th Ave
Suite 2416
New York, NY 10019-6108
United States
https://fresh2.co
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 75
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Haohan Xu | Chairman of the Board & CEO | N/A | N/A | 1995 |
Dr. He Yu | Co-Founder & Chief Scientist | N/A | N/A | 1958 |
Ms. Xiaoyu Li | Director & CFO | N/A | N/A | 1989 |
Mr. Weidong Dai | China President | N/A | N/A | 1961 |
Dr. Sunil Pandit | U.S. Chief Executive Officer | N/A | N/A | N/A |
Mr. Yidong Hu | Chief Strategy Officer | N/A | N/A | N/A |
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.
Fresh2 Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.